These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6340001)

  • 1. [Blood glucose regulation in Bartter's syndrome. Observations in 2 cases].
    Uccella R; Agosti C; Morenghi R; Morgutti M
    Minerva Med; 1983 Mar; 74(9-10):453-63. PubMed ID: 6340001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet hyporesponsiveness to epinephrine in carriers of Bartter's syndrome.
    O'Regan S; Rivard GE; Cole C; Robitaille PO
    Prostaglandins Med; 1979 May; 2(5):321-4. PubMed ID: 550149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defect in platelet aggregation in Bartter's syndrome.
    Stoff JS; Stemerman M; Steer M; Salzman E; Brown RS
    Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome.
    Di Virgilio F; Calò L; Cantaro S; Favaro S; Piccoli A; Borsatti A
    Clin Sci (Lond); 1987 Apr; 72(4):483-8. PubMed ID: 3829597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin suppresses plasma aldosterone concentration in a case of Bartter's syndrome.
    Shigeta H; Tasaki N; Kitazumi S; Kitagawa Y; Nakano K; Kanatsuna T; Kondo M
    Endocrinol Jpn; 1987 Apr; 34(2):309-12. PubMed ID: 2887425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term captopril therapy of 3 sisters with Bartter's syndrome].
    Volpi A; Meroni M; Battini G; Torri-Tarelli L; Conte F; Ferrario G; Giordano F; Tommasi A; Fabbri C; Sessa A
    Minerva Urol Nefrol; 1988; 40(1):61-6. PubMed ID: 3051444
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome.
    Mattioli M; Delva P; Lechi C; Minuz P; Lechi A; Scuro LA
    J Endocrinol Invest; 1984 Feb; 7(1):61-3. PubMed ID: 6715799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-keto-prostaglandin E1 and Bartter's syndrome.
    Jackson EK; Goodman RP
    N Engl J Med; 1981 Jul; 305(5):287. PubMed ID: 7195465
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet calmodulin concentration in essential hypertension and in Bartter's syndrome.
    Calò L; Cantaro S; Vianello A; Favaro S; Borsatti A
    Am J Nephrol; 1986; 6 Suppl 1():60-2. PubMed ID: 3103446
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of captopril in Bartter's syndrome.
    Hené RJ; Koomans HA; Boer P; Dorhout Mees EJ
    Nephron; 1983; 35(4):275. PubMed ID: 6358925
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial natriuretic peptide in Bartter's syndrome.
    Yamada K; Tajima K; Moriwaki K; Tarui S; Miyata A; Kangawa K; Matsuo H
    Lancet; 1986 Feb; 1(8475):273. PubMed ID: 2868282
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophil function in Bartter's syndrome.
    Lapointe N; Samson J; O'Regan S
    Prostaglandins Med; 1981 Jun; 6(6):647-55. PubMed ID: 6267641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bartter's syndrome].
    Linnanvuo-Laitinen M; Pirttiaho H; Huttunen K; Viinikka L
    Duodecim; 1985; 101(20):1983-6. PubMed ID: 4085359
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome.
    Korff JM; Siebens AW; Gill JR
    J Clin Invest; 1984 Nov; 74(5):1724-9. PubMed ID: 6501567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic sodium and potassium pump function in Bartter's syndrome.
    Jest P; Pedersen KE; Klitgaard NA; Thomsen N; Kjaer E; Simonsen E; Jacobsen JG
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):61-6. PubMed ID: 2741641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin and atrial natriuretic peptide in Bartter's syndrome.
    Gordon RD; Tunny TJ; Klemm SA
    N Engl J Med; 1986 Aug; 315(7):459. PubMed ID: 2942775
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin?
    MacIntyre DE; Smith M; Levine L; Stoff JS; Stemerman M; Steer ML; Salzman EW; Brown RS
    Adv Prostaglandin Thromboxane Res; 1980; 7():1199-202. PubMed ID: 7369031
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
    Watanabe S; Fukumoto S; Chang H; Takeuchi Y; Hasegawa Y; Okazaki R; Chikatsu N; Fujita T
    Lancet; 2002 Aug; 360(9334):692-4. PubMed ID: 12241879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.